ArticleFrontiers in oncology2026
A case series: Four cases of urothelial carcinoma with sarcomatoid differentiation.
Article in Frontiers in oncology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Urothelial carcinoma with sarcomatoid differentiation (UCSD) is a rare and highly aggressive variant of urothelial carcinoma associated with poor prognosis. UCSD originating in the upper urinary tract is extremely uncommon, and its variable morphological presentation, along with the lack of established treatment guidelines, often poses diagnostic and therapeutic challenges. We herein report four cases of upper tract UCSD treated with radical nephroureterectomy. All tumors exhibited varying proportions (40%-90%) of sarcomatoid components with diverse histological patterns. Postoperatively, patients received adjuvant chemotherapy. Through this case report and review of the relevant literature, we aim to enhance the understanding of this rare entity and contribute to the discussion on optimal treatment strategies for upper tract UCSD.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.